BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21168459)

  • 1. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
    Krawczyk M; Grünhage F; Zimmer V; Lammert F
    J Hepatol; 2011 Aug; 55(2):299-306. PubMed ID: 21168459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels.
    Krawczyk M; Gruenhage F; Mahler M; Tirziu S; Acalovschi M; Lammert F
    J Physiol Pharmacol; 2011 Jun; 62(3):369-75. PubMed ID: 21893698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
    Arslanow A; Stokes CS; Weber SN; Grünhage F; Lammert F; Krawczyk M
    Liver Int; 2016 Mar; 36(3):418-26. PubMed ID: 26264356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
    Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Bouillet B; Brindisi MC; Robin I; Gambert P; Verges B; Cercueil JP; Hillon P
    Liver Int; 2011 Oct; 31(9):1332-6. PubMed ID: 21745307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    Yasui K; Kawaguchi T; Shima T; Mitsuyoshi H; Seki K; Sendo R; Mizuno M; Itoh Y; Matsuda F; Okanoue T
    J Gastroenterol; 2015 Aug; 50(8):887-93. PubMed ID: 25543233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    Romeo S; Sentinelli F; Cambuli VM; Incani M; Congiu T; Matta V; Pilia S; Huang-Doran I; Cossu E; Loche S; Baroni MG
    J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
    Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
    Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of combined genetic determinants of liver stiffness within the SREBP1c-PNPLA3 pathway.
    Krawczyk M; Grünhage F; Lammert F
    Int J Mol Sci; 2013 Oct; 14(10):21153-66. PubMed ID: 24152445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.
    Trépo E; Gustot T; Degré D; Lemmers A; Verset L; Demetter P; Ouziel R; Quertinmont E; Vercruysse V; Amininejad L; Deltenre P; Le Moine O; Devière J; Franchimont D; Moreno C
    J Hepatol; 2011 Oct; 55(4):906-12. PubMed ID: 21334404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.
    Ezzikouri S; Alaoui R; Tazi S; Nadir S; Elmdaghri N; Pineau P; Benjelloun S
    Infect Genet Evol; 2014 Jan; 21():179-83. PubMed ID: 24269995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
    Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.
    Viganò M; Paggi S; Lampertico P; Fraquelli M; Massironi S; Ronchi G; Rigamonti C; Conte D; Colombo M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):353-62. PubMed ID: 21631559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.